The U.S. Court of Appeals for the District of Columbia Circuit has denied ARSA’s request to extend the FAA’s new drug and alcohol (D&A) testing program rule’s compliance date. The denial means that, per the court’s interim order issued October 11, the D&A rule’s compliance date is October 20.
While ARSA is disappointed in the Court’s decision, the Association is not surprised, as such “motions for stay” are rarely granted. However, ARSA and its legal team filed the motion in an effort to have the Association’s March 10, 2006, lawsuit against the rule decided before industry was required to comply with the regulation.
ARSA’s legal fight–specifically working diligently to win the March 10 lawsuit–against the unnecessary, burdensome D&A testing rule continues. The Association will keep its members informed of all new developments.
For information on complying with the new D&A rule, click here.
More from ARSA
July 05, 2022 | Categories:
ARSA News & Updates
The hotline – ARSA’s premier member newsletter – contains news, editorial content, analysis and resources for the aviation maintenance community. All members should ensure they receive their edition the first week of…
Read More
The FAA recently withdrew its of approval of ARSA’s E100 form, which has been used by U.S. repair stations for more than half a decade to satisfy parts documentation requirements…
Read More
The association focuses its energy on serving the aviation community. Most of ARSA’s success stems from showing rather than telling; new members predominantly come through referrals and recommendations, and old…
Read More
Aviation safety professionals from around the world gathered in Washington, D.C. June 14-16 for the 2022 FAA-EASA International Aviation Safety Conference. ARSA was represented by Executive Director Sarah MacLeod and…
Read More
Aviation took center stage on Capitol Hill in recent weeks as the House of Representatives passed legislation to improve government coordination on advanced air mobility and the Transportation & Infrastructure…
Read More
